Abstract

Patterns of spontaneous electric activity in the cerebral cortex change upon administration of benzodiazepines. Here we are testing the hypothesis that the prototypical benzodiazepine, diazepam, affects spectral power density in the low (20–50 Hz) and high (50–90 Hz) γ-band by targeting GABAA receptors harboring α1- and α2-subunits. Local field potentials (LFPs) and action potentials were recorded in the barrel cortex of wild type mice and two mutant strains in which the drug exclusively acted via GABAA receptors containing either α1- (DZα1-mice) or α2-subunits (DZα2-mice). In wild type mice, diazepam enhanced low γ-power. This effect was also evident in DZα2-mice, while diazepam decreased low γ-power in DZα1-mice. Diazepam increased correlated local LFP-activity in wild type animals and DZα2- but not in DZα1-mice. In all genotypes, spectral power density in the high γ-range and multi-unit action potential activity declined upon diazepam administration. We conclude that diazepam modifies low γ-power in opposing ways via α1- and α2-GABAA receptors. The drug’s boosting effect involves α2-receptors and an increase in local intra-cortical synchrony. Furthermore, it is important to make a distinction between high- and low γ-power when evaluating the effects of drugs that target GABAA receptors.

Highlights

  • Electroencephalographic activity in the high-frequency range (>20 Hz) is prominent during sensory processing and cognition. It is a signature of conscious cognitive functions and subject to modulation by clinically used benzodiazepines, which act by positive allosteric modulation of GABAA receptors

  • Diazepam is a prototypical benzodiazepine that targets a family of GABAA receptor subtypes containing the α1, α2, α3- or α5-subunit [1]

  • We found that modulation of α2-GABAA receptors is sufficient for increasing low γ-power

Read more

Summary

Introduction

Electroencephalographic activity in the high-frequency range (>20 Hz) is prominent during sensory processing and cognition It is a signature of conscious cognitive functions and subject to modulation by clinically used benzodiazepines, which act by positive allosteric modulation of GABAA receptors. Diazepam is a prototypical benzodiazepine that targets a family of GABAA receptor subtypes containing the α1-, α2-, α3- or α5-subunit [1] These subunits display different expression patterns in the central nervous system [2] and serve different physiological functions [3]. Their individual contribution to the overall effects of benzodiazepines on high-frequency brain activity is unknown. The effects of diazepam were investigated in two mutant mouse strains in which the drug exclusively acted via

Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call